Plus Therapeutics Presents at the Sixth Biennial Pediatric Neuro-Oncology Research Conference

NEXT STORY
Paratek Pharmaceuticals Hosting Investor Webinar with Corporate Updates and Key Opinion Leader and Patient Advocate Presentations on Non-Tuberculous Mycobacteria, M. abscessus
PREV STORY
Tonix Pharmaceuticals to Participate in BIO Digital Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ADMA Biologics Reports Third Quarter 2020 Financial Results and Business Highlights

author_avatar
NASDAQ Market News

Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer

Dr. Almenoff brings more than 20 years of pharmaceutical executive experience from GlaxoSmithKline and ...

author_avatar
NASDAQ Market News

Direct-to-Patient Market Worth US$67,897 Million by 2031. Visiongain Research Inc.

author_avatar
NASDAQ Market News